Molecular subtyping of acute myeloid leukemia through ferroptosis signatures predicts prognosis and deciphers the immune microenvironment

Acute myeloid leukemia (AML) is one of the most aggressive hematological malignancies with a low 5-year survival rate and high rate of relapse. Developing more efficient therapies is an urgent need for AML treatment. Accumulating evidence showed that ferroptosis, an iron-dependent form of programmed...

Descripción completa

Detalles Bibliográficos
Autores principales: Fu, Denggang, Zhang, Biyu, Wu, Shiyong, Feng, Jueping, Jiang, Hua
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Cell and Developmental Biology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10483833/
https://www.ncbi.nlm.nih.gov/pubmed/37691822
http://dx.doi.org/10.3389/fcell.2023.1207642

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10483833/
https://www.ncbi.nlm.nih.gov/pubmed/37691822
http://dx.doi.org/10.3389/fcell.2023.1207642

Ejemplares similares